Hologic CEO buys more than $4 million in stock
Bobby Raines 02/12/2014
Stephen MacMillan, the president and CEO of Hologic (
), bought 198,900 shares of the company's common stock on Feb. 6
and Feb. 7. At $20.75 per share, MacMillan paid a total of
$4,133,644 for the new shares.
IK-> The technicals for HOLX ($21.44 up $0.19) are bullish with a neutral trend. Recent support has been around $20.11 and recent resistance has been around $22.58. Standard & Poor's has a four STARs (out of five) rating on the stock. Look at the June 16/19 bull-put spread for a 20-cent credit. That's a 7.14% return and the stock has to fall 11.4% to cause a problem. [InvestorsKeyhole, Various news and data services]